Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.00047 | 1 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -3.3e-05 | 1 |